Researcher wins award from American Diabetes Association

May 04, 2006

A researcher at the University of Rochester Medical Center has won the 2006 Thomas R. Lee Career Development Award from the American Diabetes Association (ADA), which includes an $842,400 grant to study how diabetes dramatically increases risk for cardiovascular disease. The award recognizes the excellence in diabetes-related research achieved by Zheng-Gen Jin, Ph.D., assistant professor in the Department of Medicine and the Cardiovascular Research Institute, and supports his lab's work.

Nearly 21 million Americans have diabetes. The most life-threatening consequences of diabetes are heart diseases and stroke, which strike people with diabetes twice as often as people without the disease. More than 65 percent of deaths in diabetes patients are attributed to heart and vascular disease. Thus, researchers are seeking urgency to understand why people with diabetes are at greater risk. Dr. Jin won the award for his study, titled Molecular Basis for Diabetes-associated endothelial dysfunction, which focuses on how high blood sugar (blood glucose) in diabetes patients contributes to narrowed blood vessels, creating risk for heart attack and stroke.

Dr. Jin was chosen because his ADA grant application was found to have the highest scientific merit in a given fiscal year. The Thomas R. Lee Career Development Award is funded in full by the Estate of Mr. Thomas R. Lee of Norfolk, Virginia, through ADA Research Foundation. The ADA funding for Jin's lab begins this year and runs through 2010.

"I am honored and excited to receive the award because I believe it will help us to improve the understanding of how two deadly diseases are related," Jin said. "Both diabetes and heart disease have reached epidemic levels and are projected to get worse, so we appreciate Mr. Lee's generosity and applaud the ADA's support of the search for better, preventive treatments."

Diabetes Study Details

Diabetes mellitus is a long-term disease where patients lose, or see reduced, their ability to effectively process sugar consumed as food. They develop high blood sugar because the body does not produce (type 1 diabetes) or produces too little (type 2 diabetes) insulin, the enzyme that takes sugar from blood and carries it into the cells where it can be used to produce energy. Diabetes can change the chemical makeup of substances found in the blood, which can cause blood vessels to narrow or to clog completely. This process is called atherosclerosis, or hardening of the arteries, and diabetes seems to speed it up.

Jin's lab is focused on the role of oxidative stress in the development of atherosclerosis in patients with Type 2 diabetes. High blood glucose can stimulate the production of highly reactive molecules called free radicals from cells in blood and in blood vessel walls. Oxidative stress occurs when those free radicals overwhelm the antioxidant defence system in cells and cause unwanted reactions with sensitive molecules (e.g. DNA). Beyond the direct cellular damage, oxidative stress also reduces the bioavailability of nitric oxide (NO). NO signals muscle within blood vessels to relax, widening the artery and increasing blood flow. Less NO means blood vessels are less relaxed and open and more likely to clog. Derived from cells lining blood vessels (vascular endothelial cells), NO is believed to counter atherosclerosis.

High blood glucose in patients with diabetes impairs the performance of NO synthases (NOS), the enzymes that generate NO in response to blood flow, according to theory. Jin hopes to soon understand the molecular mechanisms behind this process on the way to creating new drugs that release more nitric oxide when needed to prevent cardiovascular disease in patients with diabetes.

"Diabetes is on the rise in the United States, yet the available funding for research hasn't increased at the same pace," said Don Wagner, chair of the American Diabetes Association Research Foundation. "That's why we believe it's so important to recognize and support the work of scientists like Dr. Jin, whose cutting-edge research is doing so much to improve the quality of life for people who suffer from this disease."

University of Rochester Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to